Osstem Implant, a South Korea-based dental implant maker, is in advanced discussions to buy ZimVie (ZIMV), Bloomberg’s Vinicy Chan reports. According to people familiar with the matter, financing is in place. ZimVie, which was spun off from Zimmer Biomet (ZBH) in 2022, has been working with an adviser after receiving interest from potential buyers and had a market value of about $517M as of Wednesday.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZIMV: